SMO was found to be elevated in both prostate adenocarcinoma and prostatic intraepithelial neoplasia [67] whereas breast cancer showed SMOX underexpression at both mRNA and protein levels [68]. The gene discussed is SMOX; the disease is prostate intraepithelial neoplasia.